Wednesday, March 04, 2015 4:29:53 PM
THIS LOVELY GENT BELOW.......
I'VE DEALT WITH HIM IN THE PAST
Ebola-C.
Before today, you may or may not have ever heard of Ebola-C. However, chances are that you will hear a lot more about in the days and weeks to come.
Ebola-C is a dietary supplement that was developed in the form of a standard wafer. The supplement was designed to prevent the breakdown of healthy cells within the human body. By doing its job efficiently, Ebola-C helps to keep those cells inside of a person’s body much longer.
According to a recent report released by TMZ, Ebola-C has been on the market since October 1st. The developer of Ebola-C, New York City businessman Todd Spinelli, claims that since that time he has sold over 14,000 packages at a rate of $34.95 each.
You would think that a supplement of this nature would have been promoted, distributed and sold all around the world by now — especially with the recent Ebola outbreak in Africa and confirmed diagnoses that seem to be spreading around the world.
However, there’s another side of Ebola-C that you need to take into consideration.
First and foremost, this dietary supplement has not been approved by the US Food and Drug Administration (FDA) — which more than likely explains why it is not being promoted and prescribed in hospitals, clinics and private practices around the world as of yet.
The developer, New York City businessman Todd Spinelli, has claimed that Ebola-C can boost the immune system which protects it from contracting diseases such as Ebola. However, there is no scientific evidence that proves any of those claims whatsoever.
Why, then, has Ebola-C been able to generate so many sales and so much money in such a relatively short period of time?
It is because people around the world are scared of the Ebola virus. Regardless of the slim odds of an outbreak or the even slimmer chances of getting diagnosed with this deadly virus, millions of people are scared.
Todd Spinelli is just one of the first people to find a way to capitalize on the Ebola scare that has spread much faster and farther than the virus itself. The average person would think (at first glance) that Ebola-C is some sort of medication that can protect you from being diagnosed with Ebola-C. However, according to the details of the package, Ebola-C is more of a Vitamin C supplement than anything else.
There have been quite a few studies (and conspiracy theories) released online recently claiming that high doses of Vitamin C can eliminate signs of the Ebola virus in the human body. However, these studies and theories have not been confirmed either.
If his claims are correct, Todd Spinelli has already generated over $480,000 in revenue by selling Ebola-C for the past two weeks.
Do you think that Ebola-C will continue to make money or get pulled off the market due to the high level of controversy surrounding it?
Read more at http://www.inquisitr.com/1541920/todd-spinelli-ebola-c-money/#7kk3OQuTp7Qd6Od6.99
MONEYMADE Talent on loan from God!
Veni, Vidi, Vici
http://investorshub.advfn.com/boards/board.aspx?board_id=15029
http://investorshub.advfn.com/boards/board.aspx?board_id=293
Recent BCRD News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/20/2024 10:25:46 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/14/2024 10:21:12 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 01/29/2024 03:16:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 10:00:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:12:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 07:35:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:30:29 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 07/14/2023 06:45:29 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 06/29/2023 08:13:41 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM